Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Pear Therapeutics, Inc. has filed 219 SEC EDGAR filings since 15 Dec 2020

SEC filing history

Showing 51-75 of 219 matching filings.

Per page
25
Current page
3
4

FORM 4 SUBMISSION

Filing date
13 Dec 2022
Reporting date
09 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
09 Dec 2022
Reporting date
09 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Nov 2022
Reporting date
11 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-261876

424B3 - PEAR THERAPEUTICS, INC. 10-Q 2022 Q3

Filing date
14 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Nov 2022
Reporting date
31 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2022
Reporting date
14 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-92635

SC 13D/A

Filing date
16 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Sep 2022
Reporting date
06 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Aug 2022
Reporting date
16 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-261876

424B3 Q2 2022 FORM 10-Q

Filing date
11 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-261876

424B3 JULY 25TH 2022 8-K

Filing date
25 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .